Drug Industry Daily
Dec. 16, 2011
| Vol.
10 No.
245
FDA Study: Numbers Provide More Understandable Drug Risk-Benefit Data vs. Text
Using numbers rather than narrative to present a prescription drug’s risks-benefit information may help consumers more accurately weigh those risks, an FDA-commissioned study finds.
This article is viewable by subscribers only. To view this article, please select an option below.
|